Product image of Mutaflor Mite (Escherichia Coli Strain Nissle 1917) supplied by GNH India

Mutaflor Mite

Active Ingredient:
Escherichia Coli Strain Nissle 1917
Origin:
EU

Mutaflor Mite (Escherichia Coli Strain Nissle 1917)

Escherichia coli Nissle 1917, the active ingredient in Mutaflor Mite, is a probiotic presented as an oral formulation for oral use. It is employed to support gastrointestinal health by helping to maintain a balanced intestinal microbiota in adults and children.

GNH India supplies Mutaflor Mite as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide across multiple regions. The company ensures quality control, regulatory compliance and reliable logistics through global distribution and timely efficient delivery.

Manufacturer / TM Owner

Ardeypharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mutaflor Mite, a probiotic containing Escherichia coli Nissle 1917, is used in gastrointestinal conditions where modulation of the intestinal microbiota is beneficial.

  • Ulcerative colitis: helps maintain remission and reduce flare‑ups.
  • Pouchitis: lowers recurrence rates after ileal‑pouch‑anal anastomosis.
  • Antibiotic‑associated diarrhea: restores microbial balance to alleviate symptoms.

How It Works

  • Mutaflor Mite delivers live Escherichia coli Nissle 1917 to the gut, where the strain adheres to the intestinal mucosa, competes with pathogenic bacteria for nutrients and binding sites, produces antimicrobial substances, and modulates host immune responses to promote a balanced microbiota and reduce inflammation.

Side Effects

Adverse reactions reported with Mutaflor Mite are generally mild and related to the gastrointestinal tract.

Common Side Effects

  • Abdominal discomfort: mild pain or cramping.
  • Flatulence: increased intestinal gas.
  • Bloating: sensation of fullness.
  • Nausea: occasional feeling of queasiness.
  • Diarrhea: loose stools.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Bacteremia or sepsis: systemic infection, primarily in severely immunocompromised patients.
  • Severe allergic reaction: rash, itching, swelling, or anaphylaxis.
  • Persistent high fever: may indicate infection.
  • Severe abdominal pain: unexplained intense pain.
  • Unexplained weight loss: significant loss without other cause.

Precautions & Warnings

When considering Mutaflor Mite, several safety aspects should be reviewed.

  • Immunocompromised patients: assess risk before use.
  • Known hypersensitivity: avoid if allergic to E. coli strains.
  • Concurrent antibiotics: consider timing to preserve probiotic viability.
  • Pediatric use: follow prescriber guidance for children.
  • Pregnancy and lactation: consult healthcare professional due to limited data.
  • Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Avoid Interactions

Mutaflor Mite may interact with other medicines or substances.

Major Interactions (Avoid)

  • Systemic antibiotics: may eradicate the probiotic strain, reducing efficacy.
  • Immunosuppressive therapy: increased risk of infection with live bacteria.

Moderate Interactions (Monitor Closely)

  • Antacids or acid‑reducing agents: may alter gastric pH and affect bacterial survival.
  • Other probiotic products: potential competition or additive effects.
  • Antifungal agents: may impact gut flora balance indirectly.

Frequently Asked Questions

Mutaflor Mite is a probiotic containing Escherichia coli Nissle 1917 that is used to support gastrointestinal health, particularly for maintaining remission in ulcerative colitis, preventing pouchitis recurrence, and managing antibiotic‑associated diarrhea by restoring a balanced gut microbiota.

The strain colonises the intestinal lining, competes with harmful bacteria for nutrients and adhesion sites, produces antimicrobial substances, and interacts with the host immune system to reduce inflammation and promote a stable, diverse microbial community.

The dosage of Mutaflor Mite is determined by the prescribing healthcare professional based on the individual’s condition, age, and clinical response. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Safety data for Mutaflor Mite in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits and risks before prescribing it to pregnant or nursing women.

To order Mutaflor Mite, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mutaflor Mite contains a single, well‑studied strain (E. coli Nissle 1917) with documented efficacy in ulcerative colitis and pouchitis, whereas many other probiotics combine multiple strains with broader but less specific evidence. The choice depends on the clinical indication and physician preference.

Mutaflor Mite should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keeping the product sealed until use helps maintain bacterial viability.

Mutaflor Mite is taken orally, usually as a capsule or sachet, according to the prescriber’s directions. It may be swallowed with water and can be taken with or without food, depending on the specific recommendation.

The most serious risks include systemic infection such as bacteremia or sepsis, especially in severely immunocompromised individuals, and severe allergic reactions that may present as rash, swelling or anaphylaxis. Any signs of infection or allergic response should prompt immediate medical attention.

Mutaflor Mite should be avoided in patients with known hypersensitivity to E. coli strains, in those who are severely immunocompromised without medical supervision, and in individuals where the prescriber determines the risks outweigh the benefits.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Escherichia Coli Strain Nissle 1917

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT